Home LiteratureArticle Details
PMID: 11784781 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Contrasting, species-dependent modulation of copper-mediated neurotoxicity by the Alzheimer's disease amyloid precursor protein.

White AR, Multhaup G, Galatis D, McKinstry WJ, Parker MW, Pipkorn R, Beyreuther K, Masters CL, Cappai R

Abstract

The amyloid precursor protein (APP) of Alzheimer's disease (AD) has a copper binding domain (CuBD) located in the N-terminal cysteine-rich region that can strongly bind copper(II) and reduce it to Cu(I) in vitro. The CuBD sequence is similar among the APP family paralogs [amyloid precursor-like proteins (APLP1 and APLP2)] and its orthologs (including Drosophila melanogaster, Xenopus laevis, and Caenorhabditis elegans), suggesting an overall conservation in its function or activity. The APP CuBD is involved in modulating Cu homeostasis and amyloid beta peptide production. In this paper, we demonstrate for the first time that Cu-metallated full-length APP ectodomain induces neuronal cell death in vitro. APP Cu neurotoxicity can be induced directly or potentiated through Cu(I)-mediated oxidation of low-density lipoprotein, a finding that may have important implications for the role of lipoproteins and membrane cholesterol composition in AD. Cu toxicity induced by human APP, Xenopus APP, and APLP2 CuBDs is dependent on conservation of histidine residues at positions corresponding to 147 and 151 of human APP. Intriguingly, APP orthologs with different amino acid residues at these positions had dramatically altered Cu phenotypes. The corresponding C. elegans APL-1 CuBD, which has tyrosine and lysine residues at positions 147 and 151, respectively, strongly protected against Cu-mediated lipid peroxidation and neurotoxicity in vitro. Replacement of histidines 147 and 151 with tyrosine and lysine residues conferred this neuroprotective Cu phenotype to human APP, APLP2, and Xenopus APP CuBD peptides. Moreover, we show that the toxic and protective CuBD phenotypes are associated with differences in Cu binding and reduction. These studies identify a significant evolutionary change in the function of the CuBD in modulating Cu metabolism. Our findings also suggest that targeting of inhibitors to histidine residues at positions 147 and 151 of APP could significantly alter the oxidative potential of APP.

MeSH 主题词
Alzheimer Disease/metabolism Amyloid beta-Protein Precursor/chemistry,metabolism,toxicity Animals Binding Sites/genetics,physiology Caenorhabditis elegans Cells, Cultured Conserved Sequence/genetics,physiology Copper/toxicity Drosophila Glycine/chemistry Humans Lipid Peroxidation/drug effects Lipoproteins, LDL/drug effects,metabolism Mice Mutagenesis, Site-Directed Neurons/cytology,drug effects,metabolism Organometallic Compounds/chemistry Oxidation-Reduction/drug effects Peptide Fragments/chemistry,metabolism,toxicity Protein Structure, Tertiary/genetics,physiology Recombinant Proteins/chemistry,metabolism,toxicity Sequence Homology, Amino Acid Species Specificity Structure-Activity Relationship Takifugu Xenopus
化学物质
Amyloid beta-Protein Precursor Lipoproteins, LDL Organometallic Compounds Peptide Fragments Recombinant Proteins cupric glycinate Copper Glycine
作者与单位
共 9 位作者,点击展开单位 / ORCID
White Anthony R
Department of Pathology, The University of Melbourne, Victoria 3010, Australia.
Multhaup Gerd
Galatis Denise
McKinstry William J
Parker Michael W
Pipkorn Rüdiger
Beyreuther Konrad
Masters Colin L
Cappai Roberto
Article Info
Journal
The Journal of neuroscience : the official journal of the Society for Neuroscience
Abbr.
J Neurosci
ISSN
1529-2401
Published
2002-01-15
页码
365-76
Language
English
Country/Region
United States
NLM ID
8102140
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com